Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Protecting stem cell-derived beta-cells transplants without immunosuppressants
FY 2022-23
Summary
Type 1 diabetes (T1D) is an autoimmune disease where the pancreatic insulin-producing, ?-cells, are destroyed, causing high blood sugar levels. At present there is no cure, and those with T1D need lifelong insulin therapy to maintain healthy blood glucose levels. Even with the availability of insulin pumps, administration of insulin still does not replicate the precise regulation of ?-cells. Transplanting insulin-producing cells from organ donors is a new therapy that removes the need for those with T1D to inject insulin. Since organ donors are scarce, vary in quality and transplant recipients require drugs to prevent immune rejection, stem cells are a promising resource for the replacement of ?-cells since we can create them in infinite supply and modify stem cell genes. This can allow us to make ?-cells that can protect themselves from the immune system. Here I propose to generate stem cell-derived insulin-producing cells that produce a protein that I hypothesize will block the immune system from attacking. I will transplant these genetically modified ?-cells into mice with T1D to see if their blood sugar levels return to normal and understand if these cells are protected from immune destruction. This project will add to the toolkit for designing the ideal stem cell-derived insulin-producing cell source that could be transplanted into Canadians that live with T1D.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486330
Name
Filatov Ekaterina
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Protecting stem cell-derived beta-cells transplants without immunosuppressants
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Beta-Cells; Cell Transplantation; Cell-Therapy; Genome Editing; Graft Protection; Immune Surveillance; Insulin-Secretion; Pluripotent Stem Cells; T Regulatory Cells; Type 1 Diabetes
Abstract
Type 1 diabetes (T1D) is an autoimmune disease where the pancreatic insulin-producing, ?-cells, are destroyed, causing high blood sugar levels. At present there is no cure, and those with T1D need lifelong insulin therapy to maintain healthy blood glucose levels. Even with the availability of insulin pumps, administration of insulin still does not replicate the precise regulation of ?-cells. Transplanting insulin-producing cells from organ donors is a new therapy that removes the need for those with T1D to inject insulin. Since organ donors are scarce, vary in quality and transplant recipients require drugs to prevent immune rejection, stem cells are a promising resource for the replacement of ?-cells since we can create them in infinite supply and modify stem cell genes. This can allow us to make ?-cells that can protect themselves from the immune system. Here I propose to generate stem cell-derived insulin-producing cells that produce a protein that I hypothesize will block the immune system from attacking. I will transplant these genetically modified ?-cells into mice with T1D to see if their blood sugar levels return to normal and understand if these cells are protected from immune destruction. This project will add to the toolkit for designing the ideal stem cell-derived insulin-producing cell source that could be transplanted into Canadians that live with T1D.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Filatov, Ekaterina
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~